Latest news
Loading news…
Initial Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. South San Francisco, California, United States Founded 2020 11-50 employees For Profit
Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
17
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 35
- IT spend
- $204K
Company Info
- Founded
- 2020
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 13
- HQ
- South San Francisco, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0.4
- Trend (30d)
- 3.6
- Trend (90d)
- 1.6
- Last leadership hire
- Apr 18, 2024
Key People at Initial Therapeutics
President and CEO
17
professional contacts at Initial Therapeutics
Contact execs at Initial Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Initial Therapeutics
Loading news…
FAQs about Initial Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.